Jazz Hits Roxane With Patent Suit Over Xyrem
Jazz Pharmaceuticals Inc. slapped a Boehringer Ingelheim Corp. subsidiary with another patent infringement suit Monday in New Jersey over its bid for approval to market a generic version of Jazz's narcolepsy...To view the full article, register now.
Already a subscriber? Click here to view full article